1. Alexion says “no” to investor proactive sale demand — FDA approves first copycats of Novartis MS drug Gilenya — $178M stockpile of Merck ebola vaccine authorized — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Insight Health

Anonymous board for Insight Health

Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    1
    Views:
    3,014
  2. Anonymous
    Replies:
    0
    Views:
    2,026
  3. Anonymous
    Replies:
    27
    Views:
    10,979
  4. Anonymous
    Replies:
    89
    Views:
    22,154
  5. Anonymous
    Replies:
    32
    Views:
    9,271
  6. Anonymous
    Replies:
    3
    Views:
    3,447
  7. Anonymous
    Replies:
    14
    Views:
    3,824
  8. Anonymous
    Replies:
    3
    Views:
    3,644
  9. Anonymous
    Replies:
    19
    Views:
    6,024
  10. Anonymous
    Replies:
    2
    Views:
    3,436
  11. Anonymous
    Replies:
    14
    Views:
    4,434

Thread Display Options

Loading...